← Back to Search

Cannabinoid

Cannabidiol for Veterans' Health and Well-being

N/A
Waitlist Available
Led By Laura Stewart, PhD
Research Sponsored by University of Northern Colorado
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up twice, separated by 1 week, prior to the start of the intervention and weekly during the 4 week intervention

Summary

This trial will explore how the hemp derivative CBD affects overall health, pain, anxiety, depression and sleep in US veterans.

Who is the study for?
This trial is for US veterans over 18 with internet access who can consent to participate. It's not for pregnant individuals, those planning pregnancy, using illegal drugs, living in states with CBD restrictions, traveling outside the US during the study, allergic to capsule ingredients or having uncontrolled chronic diseases and certain medication use.
What is being tested?
The trial tests if a 4-week course of Vantage Hemp CBD improves overall health, pain relief, anxiety reduction, depression alleviation and sleep quality in veterans compared to a placebo. Participants will be randomly assigned to receive either CBD or placebo capsules.
What are the potential side effects?
While specific side effects are not listed here as it's testing efficacy primarily on healthy subjects without significant health challenges; generally known potential side effects of CBD include fatigue, changes in appetite and weight, diarrhea and interactions with other medications.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~twice, separated by 1 week, prior to the start of the intervention and weekly during the 4 week intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and twice, separated by 1 week, prior to the start of the intervention and weekly during the 4 week intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Beck Depression Inventory Score
Change in Defense and Veterans Pain Rating Scale Score
Change in General Anxiety Disorder Questionnaire Score
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: CBD CapsuleExperimental Treatment1 Intervention
Participants will take capsules containing 50 mg of CBD daily for 4 weeks.
Group II: Placebo CapsulePlacebo Group1 Intervention
Participants will take placebo capsules containing 0 mg of CBD daily for 4 weeks.

Find a Location

Who is running the clinical trial?

University of Northern ColoradoLead Sponsor
6 Previous Clinical Trials
417 Total Patients Enrolled
Laura Stewart, PhDPrincipal InvestigatorUniversity of Northern Colorado
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

Cannabidiol (Cannabinoid) Clinical Trial Eligibility Overview. Trial Name: NCT05850754 — N/A
Healthy Subjects Research Study Groups: CBD Capsule, Placebo Capsule
Healthy Subjects Clinical Trial 2023: Cannabidiol Highlights & Side Effects. Trial Name: NCT05850754 — N/A
Cannabidiol (Cannabinoid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05850754 — N/A
~5 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top